Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection

Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection

Colorectal cancer (CRC) remains a leading cause of cancer-related mortality despite efforts to improve standard interventions. As CRC patients can benefit from immunotherapeutic strategies that incite effector T cell action, cancer vaccines represent a safe and promising therapeutic approach to elic...

Full description

Bibliographic Details
Main Authors: Trevor S. Anderson, Amanda L. McCormick, Elizabeth A. Daugherity, Mariam Oladejo, Izuchukwu F. Okpalanwaka, Savanna L. Smith, Duke Appiah, Laurence M. Wood, Devin B. Lowe
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:OncoImmunology
Subjects:
Anti-angiogenic vaccine
colon cancer
listeria monocytogenes
pericyte
RGS5
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2023.2260620

Internet

https://www.tandfonline.com/doi/10.1080/2162402X.2023.2260620

Similar Items